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BCG VACCINATION AND TB IN CHILDREN
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Turner and colleagues do not accept our conclusion that BCG
preventsMycobacterium tuberculosis infection without a valid
mechanism and propose an alternative hypothesis for an apparent
effect.1 2 We presented the consistent epidemiological finding
of a protective effect of BCG against tuberculosis infection
rather than speculating on a mechanism of action for this effect,
which was not one of the stated objectives of our meta-analysis.
Absence of a valid mechanism is not usually a basis for rejecting
conclusions from consistently observed findings.3 Indeed, the
protective effect of BCG against tuberculosis is not in doubt,
even though a mechanism (and a correlate) of protection remain
elusive after decades of investigation.4 Nonetheless, we believe
that new vaccines for tuberculosis will be found only if we
undertake more research to disentangle the mechanism of action
of BCG vaccines, including their effects on innate and adaptive
immune responses.5
Turner and colleagues’ explanation, based on the fact that
antigens used in the interferon γ release assay (IGRA) are absent
from BCG, is undermined by the protective effect of BCG
against tuberculosis infection when the tuberculin skin test
(TST) is used instead of IGRA as a marker of infection.6 7
Purified protein derivative comprises hundreds ofM tuberculosis
antigens shared by BCG, so that TST results in these studies
could not be subject to “original antigenic sin.” The observation
in our review of BCG and active tuberculosis that people
sensitised to tuberculin are less protected further argues for the
vaccine’s role in protecting against infection.8 9
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